Abstract
We developed a staging scheme for assessing pathology in frontotemporal lobar degeneration (FTLD), which relates to atrophy and accounts for the large variability seen at postmortem (Broe et al. 2003;60:1005-11). Atrophy of the temporal lobe has the most linear relationship to disease stage. We review how this simple staging technique has been applied in clinical settings, where it is the best predictor of survival and discriminates semantic dementia and behavioural phenocopies. Patients with clinical presentations of motor neuron disease or progressive supranuclear palsy have significantly lower disease stages than other FTLD syndromes. We also review the pathologies relating to disease stage. There is no significant difference in the overall distribution of stages between the different pathological subtypes of FTLD, indicating a similar underlying disease process. The cellular variables relating independently to increasing disease stage are (1) increasing neuronal loss, astrocytosis and microvacuolation, and (2) increasing glial apoptosis. Of note, the degree of protein deposition does not relate to disease stage.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bak TH, Hodges JR (2008) Corticobasal degeneration: clinical aspects. Handbook of Clinical Neurology 89:509–521
Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259
Broe GA, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM (2003) Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60:1005–1011
Broe M, Kril JJ, Halliday GM (2004) Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 127:2214–2220
Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH (2005) The pathological basis of semantic dementia. Brain 128:1984–1995
Davies RR, Kipps CM, Mitchell J, Kril JJ, Halliday GM, Hodges JR (2006) Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 63:1627–1631
Davies RR, Halliday GM, Xuereb JH, Kril JJ, Hodges JR (2009) The neural basis of semantic memory: evidence from semantic dementia. Neurobiol Aging 30:2043–2052
Hodges JR, Davies R, Xuereb J, Kril J, Halliday GM (2003) Survival in frontotemporal dementia. Neurology 61:349–354
Josephs KA, Petersen RC, Knopman DS et al (2006) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66:41–48
Josephs KA, Whitwell JL, Weigand SD et al (2011) Predicting functional decline in behavioural variant frontotemporal dementia. Brain 134:432–448
Kersaitis C, Halliday G, Kril JJ (2004) Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without pick bodies. Acta Neuropathologica (Berlin) 108:515–523
Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128:1996–2005
Kipps CM, Davies RR, Mitchell J, Kril JJ, Halliday GM, Hodges JR (2007) Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cognit Disord 23:334–342
Kril JJ, Halliday GM (2004) Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy. Dement Geriatr Cognit Disord 17:311–315
Kril JJ, Macdonald V, Patel S, Png F, Halliday GM (2005) Distribution of brain atrophy in behavioural variant frontotemporal dementia. J Neurol Sci 232:83–90
Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR (2011) How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler 12:45–51
Lomen-Hoerth C, Anderson T, Miller BL (2001) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59:1077–1079
Mackenzie IRA, Neumann M, Bigio EH et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1–4
Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR (2010) Clinical staging and disease progression in frontotemporal dementia. Neurology 74:1591–1597
Piguet O, Halliday GM, Reid WGJ et al (2011) Clinical phenotypes in autopsy-confirmed Pick disease. Neurology 76:253–259
Schofield E, Kersaitis C, Shepherd CE, Kril JJ, Halliday GM (2003) Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. Brain 126:827–840
Schofield EC, Caine D, Kril JJ, Cordato NJ, Halliday GM (2005) Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration. Mov Disord 20:34–39
Short RA, Broderick DF, Patton A, Arvanitakis Z, Graff-Radford NR (2005) Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes. Arch Neurol 62:1106–1110
Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EPJ (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559–577
Whitwell JL, Jack CR Jr, Parisi JF et al (2007) Rates of cerebral atrophy differ in different degenerative pathologies. Brain 130:1148–1158
Acknowledgements
The authors are grateful to Ms. Heidi Cartwright for preparing the figure. The authors' research has been supported by the National Health and Medical Research Council of Australia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kril, J.J., Halliday, G.M. Pathological Staging of Frontotemporal Lobar Degeneration. J Mol Neurosci 45, 379–383 (2011). https://doi.org/10.1007/s12031-011-9528-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9528-0